Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 2/2011

01-04-2011 | Editorial

Will the epidemic of diabetes in India subside?

Author: Hemraj B. Chandalia

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2011

Login to get access

Excerpt

The epidemiologists have been prolific in disseminating the data on the cross-sectional and follow-up studies on the high prevalence of diabetes in India and predicting its alarming trends [14]. This journal has carried several articles [510] further bringing out the data on the differences between urban and rural prevalence of diabetes. This issue of the journal contains an article showing the difference in the cardiovascular risk factors in the rural versus urban population [11]. This has served a useful purpose of bringing in focus the double-burden of transiting communicable diseases and newly entering non-communicable diseases. This has helped the government and Indian council of Medical Research to further strategize regarding the prevention of diabetes. …
Literature
1.
go back to reference King H, Herman WH. Global burden of diabetes 1995–2025; prevalence, numerical estimates, and projection. Diabetes Care. 1998;21:1414–31.PubMedCrossRef King H, Herman WH. Global burden of diabetes 1995–2025; prevalence, numerical estimates, and projection. Diabetes Care. 1998;21:1414–31.PubMedCrossRef
2.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRef Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.PubMedCrossRef
3.
go back to reference Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997;40:232–7.PubMedCrossRef Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia. 1997;40:232–7.PubMedCrossRef
4.
go back to reference Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094–101.PubMedCrossRef Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al. Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia. 2001;44:1094–101.PubMedCrossRef
5.
go back to reference Deo SS, Zantye A, Mokal R, Mithbhawkar S, Rane S, Thakur K. To identify the risk factors for high prevalence of diabetes and impaired glucose tolerance in Indian Rural population. Int J Diab Dev Ctries. 2006;26:19–23.CrossRef Deo SS, Zantye A, Mokal R, Mithbhawkar S, Rane S, Thakur K. To identify the risk factors for high prevalence of diabetes and impaired glucose tolerance in Indian Rural population. Int J Diab Dev Ctries. 2006;26:19–23.CrossRef
6.
go back to reference Kokiwar PR, Gupta S, Durge PM. Prevalence of Diabetes in a rural area of central India. Int J Diab Dev Ctries. 2007;27:8–10.CrossRef Kokiwar PR, Gupta S, Durge PM. Prevalence of Diabetes in a rural area of central India. Int J Diab Dev Ctries. 2007;27:8–10.CrossRef
7.
go back to reference Purti AJ, Vedapriya DR, Bazroy J, Gupta S, Cherian J, Viswanathan M. Prevalence of diagnosed diabetes in an urban area of Puducheri, India: Time for preventive action. Int J Diab Dev Ctries. 2009;29:6–11.CrossRef Purti AJ, Vedapriya DR, Bazroy J, Gupta S, Cherian J, Viswanathan M. Prevalence of diagnosed diabetes in an urban area of Puducheri, India: Time for preventive action. Int J Diab Dev Ctries. 2009;29:6–11.CrossRef
8.
go back to reference Gupta SK, Singh Z, Purti AJ, Vishwanathan M. Diabetes prevalence and its risk factors in Urban Pondicherry. Int J Diab Dev Ctries. 2009;29:166–9.CrossRef Gupta SK, Singh Z, Purti AJ, Vishwanathan M. Diabetes prevalence and its risk factors in Urban Pondicherry. Int J Diab Dev Ctries. 2009;29:166–9.CrossRef
9.
go back to reference Muninarayana C, Balachandra G, Hiremath SG, Iyengar K, Anil NS. Prevalence and awareness regarding diabetes mellitus in rural Tamaka, Kolar. Int J Diab Dev Ctries. 2010;30:18–21.CrossRef Muninarayana C, Balachandra G, Hiremath SG, Iyengar K, Anil NS. Prevalence and awareness regarding diabetes mellitus in rural Tamaka, Kolar. Int J Diab Dev Ctries. 2010;30:18–21.CrossRef
10.
go back to reference Rao CR, Kamath VG, Shetty A, Kamath A. A study on the prevalence of type 2 diabetes in Coastal Karnataka. Int J Diab Dev Ctries. 2010;30:80–5.CrossRef Rao CR, Kamath VG, Shetty A, Kamath A. A study on the prevalence of type 2 diabetes in Coastal Karnataka. Int J Diab Dev Ctries. 2010;30:80–5.CrossRef
11.
go back to reference Misra R, Misra A, Kamalamma N, Vikram NK, Gupta S, Sharma S, et al. Difference in prevalence of diabetes, obesity, metabolic syndrome and associated cardiovascular risk factors in a rural area of Tamil Nadu and an urban area of Delhi. Int J Diabetes Dev Ctries 2011;31:_____ Misra R, Misra A, Kamalamma N, Vikram NK, Gupta S, Sharma S, et al. Difference in prevalence of diabetes, obesity, metabolic syndrome and associated cardiovascular risk factors in a rural area of Tamil Nadu and an urban area of Delhi. Int J Diabetes Dev Ctries 2011;31:_____
12.
go back to reference King H, Rewers M. Global estimates of diabetes mellitus and impaired glucose tolerance in adults: WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16:157–77.PubMedCrossRef King H, Rewers M. Global estimates of diabetes mellitus and impaired glucose tolerance in adults: WHO Ad Hoc Diabetes Reporting Group. Diabetes Care. 1993;16:157–77.PubMedCrossRef
13.
go back to reference Ramachandran A, Snehalatha C, Vijay V. Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban south India. Diabetes Res Clin Pract. 2002;58:55–60.PubMedCrossRef Ramachandran A, Snehalatha C, Vijay V. Temporal changes in prevalence of type 2 diabetes and impaired glucose tolerance in urban south India. Diabetes Res Clin Pract. 2002;58:55–60.PubMedCrossRef
14.
go back to reference Mohan V, Deepa M, Deepa R, Shantirani CS, Farooq S, Ganesan A, et al. Secular trends in the prevalence of diabetes and glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia. 2006;49:1175–8.PubMedCrossRef Mohan V, Deepa M, Deepa R, Shantirani CS, Farooq S, Ganesan A, et al. Secular trends in the prevalence of diabetes and glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia. 2006;49:1175–8.PubMedCrossRef
16.
go back to reference Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chattergee A, et al. High prevalence of insulin resistance in postpubertal Asian Indian children isassociated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J of Obesity. 2004;28:1217–26.CrossRef Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chattergee A, et al. High prevalence of insulin resistance in postpubertal Asian Indian children isassociated with adverse truncal body fat patterning, abdominal adiposity and excess body fat. Int J of Obesity. 2004;28:1217–26.CrossRef
17.
go back to reference Grifftihs P, Bently M. Women of higher socio-economic status are more likely tobe overweight in Karnataka. India Eur J Clin Nutr. 2005;59:1217–20.CrossRef Grifftihs P, Bently M. Women of higher socio-economic status are more likely tobe overweight in Karnataka. India Eur J Clin Nutr. 2005;59:1217–20.CrossRef
18.
go back to reference Pekkanan J, Uutela A, Valkonen T, Vartiainen E, Tuomilehto J, Puska P. Coronary risk factor levels: differences between educational groups in 1972–87 in eastern Finland. J Epidemiol Community Health. 1995;49:144–9.CrossRef Pekkanan J, Uutela A, Valkonen T, Vartiainen E, Tuomilehto J, Puska P. Coronary risk factor levels: differences between educational groups in 1972–87 in eastern Finland. J Epidemiol Community Health. 1995;49:144–9.CrossRef
19.
go back to reference Srinath Reddy K et al. The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS med. 2010;7:1–12. Srinath Reddy K et al. The effect of rural-to-urban migration on obesity and diabetes in India: a cross-sectional study. PLoS med. 2010;7:1–12.
20.
go back to reference Pasala SK, Rao AA, Sridhar GR. Built environment and diabetes. Int J Diab Dev Ctries. 2010;30:63–8.CrossRef Pasala SK, Rao AA, Sridhar GR. Built environment and diabetes. Int J Diab Dev Ctries. 2010;30:63–8.CrossRef
21.
go back to reference Nathan DM. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347:1342–9.PubMedCrossRef Nathan DM. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347:1342–9.PubMedCrossRef
22.
go back to reference Tuomilehto J, Lindstrom J, Eriksson J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef Tuomilehto J, Lindstrom J, Eriksson J, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.PubMedCrossRef
Metadata
Title
Will the epidemic of diabetes in India subside?
Author
Hemraj B. Chandalia
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
International Journal of Diabetes in Developing Countries / Issue 2/2011
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-011-0027-1

Other articles of this Issue 2/2011

International Journal of Diabetes in Developing Countries 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.